Amgen Inc.
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All AMGN news ›Morgan Stanley Issues a Hold Rating on Amgen (AMGN)
In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating to Amgen, with a price target of $362.00. Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Merck & Company, and Amgen.…
What Would It Take For Amgen Stock To Move Higher?
Amgen (AMGN) stock has returned 44% over the past twelve months, easily outpacing the 17.1% gain for the S&P 500. Investors looking at that rally might question what catalysts remain to push shares higher. One candidate is an experimental…
Amgen Inc. $AMGN Stake Lifted by Stokes Capital Advisors LLC
MarketBeat Amgen Inc. $AMGN Stake Lifted by Stokes Capital Advisors LLC - Stokes Capital Advisors increased its Amgen stake by 187.8% in the third quarter, acquiring 5,750 additional shares for a total of 8,811 shares valued at…
Amgen Inc. $AMGN Stock Sold by Avity Investment Management Inc.
MarketBeat Amgen Inc. $AMGN Stock Sold by Avity Investment Management Inc. - Avity Investment Management reduced its Amgen stake by 8.2% in the third quarter, selling 6,228 shares and retaining 69,958 shares valued at approximately $29.5…
Amgen (NASDAQ:AMGN) Rating Lowered to Hold at Wall Street Zen
MarketBeat Amgen (NASDAQ:AMGN) Rating Lowered to Hold at Wall Street Zen - Wall Street Zen downgraded Amgen from “Buy” to “Hold.” The broader analyst consensus is also “Hold,” with 16 Hold, 10 Buy, 3 Sell and 1 Strong Buy ratings,…
Amgen Inc. $AMGN Stock Sold by Castle Rock Wealth Management LLC
MarketBeat Amgen Inc. $AMGN Stock Sold by Castle Rock Wealth Management LLC - Castle Rock Wealth Management reduced its Amgen stake by 34% in the third quarter, selling 3,186 shares and retaining 6,194 shares valued at approximately $2.5…
Amgen (AMGN) Backs $30 Million Series A Round In AI Genetic Testing
Amgen (NasdaqGS:AMGN) took part in Arboretum LifeSciences' US$30 million Series A funding round focused on precision medicine. Arboretum LifeSciences plans to apply AI-driven genetic testing and molecular data tools to support more…
Amgen (AMGN) Stock Is Up, What You Need To Know
Shares of biotech company Amgen (NASDAQ: AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel. After the initial…
Amgen Inc. $AMGN Stock Position Raised by Mn Services Vermogensbeheer B.V.
MarketBeat Amgen Inc. $AMGN Stock Position Raised by Mn Services Vermogensbeheer B.V. - Institutional ownership increased: Mn Services Vermogensbeheer raised its Amgen stake by 1.8% to 159,819 shares valued at $67.4 million. Hedge funds…
Why Amgen (AMGN) Stock Is Trading Up Today
Shares of biotech company Amgen (NASDAQ: AMGN) jumped 3.1% in the afternoon session after the company reported strong second-quarter 2026 financial results that beat expectations and prompted it to raise its full-year guidance. Total…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com40
-
investments.halifax.co.uk30
-
moneymorning.com18
-
finance.yahoo.com14
-
marketbeat.com9
Measured across the 4Bellevue news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.